Literature DB >> 6024892

The production of carbon monoxide from hemoglobin in vivo.

R F Coburn, W J Williams, P White, S B Kahn.   

Abstract

Dogs anesthetized with pentobarbital were shown to produce carbon monoxide at an average rate of 0.21 +/- (SD) 0.05 ml per hour. After intravenous injection of erythrocytes damaged by incubation with N-ethylmaleimide, CO was produced in excess of base-line production for 3 to 4 hours with an average yield of 0.89 +/- (SE) 0.046 mumole of carbon monoxide to 1 mumole of heme degraded. After intravenous injection of N-ethylmaleimide (NEM)-treated erythrocytes containing hemoglobin labeled with (14)carbon, (14)CO was produced. Its specific activity was approximately one-eighth that of the injected heme. It was also produced after intravenous injection of solutions of hemoglobin-(14)C and of reconstituted methemoglobin containing hemin-(14)C, but not after injections of methemoglobin containing globin-(14)C. The average yields of (14)CO from metabolized heme in the experiments with damaged erythrocytes and hemoglobin solutions were 89 +/- (SE) 4.6 and 97 +/- (SE) 17.0%, respectively. These results demonstrate that the CO produced during hemoglobin degradation arises from the heme moiety. The yield of (14)CO after injection of hemoglobin-(14)C solutions decreased significantly to values of 35 and 42% in two experiments when exogenous CO was added to the body stores, resulting in blood carboxyhemoglobin levels of 11.3 and 13.2% saturation. This finding suggests that oxidative metabolism is required during catabolism of hemoglobin to CO and that carboxy-hemoglobin levels in this range are sufficient to cause inhibition. After intravenous injection of either hemin-(14)C or protoporphyrin-(14)C, (14)CO was also produced. After injection of protoporphyrin-(14)C labeled bilirubin was isolated from gall bladder bile, and labeled hemin was isolated from the liver. It is thus very likely that protoporphyrin is converted to heme before the formation of CO. There was a large difference between the maximal rates of catabolism of hemoglobin to CO observed after injection of damaged erythrocytes and hemoglobin solutions. The limiting parameters in these processes are not yet clear.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6024892      PMCID: PMC297055          DOI: 10.1172/JCI105536

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  20 in total

1.  LIQUID SCINTILLATION COUNTING OF C14-LABELED HEMOGLOBIN AND HEMIN BY A MODIFIED SCHOENIGER TECHNIQUE.

Authors:  D G NATHAN; T G GABUZDA; F H GARDNER
Journal:  J Lab Clin Med       Date:  1963-09

2.  THE CONVERSION OF HEMATIN TO BILE PIGMENT IN THE RAT.

Authors:  A L SNYDER; R SCHMID
Journal:  J Lab Clin Med       Date:  1965-05

3.  Pulmonary capillary blood volume in dog: effects of 5-hydroxytryptamine.

Authors:  R C YOUNG; H NAGANO; T R VAUGHAN; N C STAUB
Journal:  J Appl Physiol       Date:  1963-03       Impact factor: 3.531

4.  Studies on the structure of hemoglobin. II. Properties of reconstituted protohemoglobin and protoporphyrin-globin.

Authors:  A ROSSI-FANELLI; E ANTONINI; A CAPUTO
Journal:  Biochim Biophys Acta       Date:  1959-09

5.  The IX-alpha structure of the common bile pigments.

Authors:  C H GRAY; D C NICHOLSON; R A NICOLAUS
Journal:  Nature       Date:  1958-01-18       Impact factor: 49.962

6.  A modification of the benzidine method for measurement of hemoglobin in plasma and urine.

Authors:  W H CROSBY; F W FURTH
Journal:  Blood       Date:  1956-04       Impact factor: 22.113

7.  The Absorption of Oxygen by the Lungs.

Authors:  J Haldane; J L Smith
Journal:  J Physiol       Date:  1897-11-20       Impact factor: 5.182

8.  The formation of bilirubin from hemoglobin in vivo.

Authors:  J D OSTROW; J H JANDL; R SCHMID
Journal:  J Clin Invest       Date:  1962-08       Impact factor: 14.808

9.  The reaction of cytochrome oxidase with carbon monoxide.

Authors:  E G BALL; C F STRITTMATTER; O COOPER
Journal:  J Biol Chem       Date:  1951-12       Impact factor: 5.157

10.  Endogenous carbon monoxide production in patients with hemolytic anemia.

Authors:  R F Coburn; W J Williams; S B Kahn
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

View more
  15 in total

1.  Haematological and cardiorespiratory responses to induced hyperpyrexia.

Authors:  W W Stoyka; M B Garvey
Journal:  Can Anaesth Soc J       Date:  1974-05

Review 2.  Carbon monoxide detection and biological investigations.

Authors:  D K Stevenson; H J Vreman; R J Wong; P A Dennery; C H Contag
Journal:  Trans Am Clin Climatol Assoc       Date:  2000

3.  Population pharmacokinetic analysis of carboxyhaemoglobin concentrations in adult cigarette smokers.

Authors:  Carol Cronenberger; Diane R Mould; Hans-Juergen Roethig; Mohamadi Sarkar
Journal:  Br J Clin Pharmacol       Date:  2007-08-31       Impact factor: 4.335

4.  Formation of carbon monoxide and bile pigment in red and blue-green algae.

Authors:  R F Troxler; J M Dokos
Journal:  Plant Physiol       Date:  1973-01       Impact factor: 8.340

5.  Carbon monoxide production from heme compounds by bacteria.

Authors:  R R Engel; J M Matsen; S S Chapman; S Schwartz
Journal:  J Bacteriol       Date:  1972-12       Impact factor: 3.490

6.  What is clinical smoke poisoning?

Authors:  B A Zikria; D C Budd; F Floch; J M Ferrer
Journal:  Ann Surg       Date:  1975-02       Impact factor: 12.969

7.  Respiratory function of the placenta as determined with carbon monoxide in sheep and dogs.

Authors:  L D Longo; G G Power; R E Forster
Journal:  J Clin Invest       Date:  1967-05       Impact factor: 14.808

8.  Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide.

Authors:  S A Landaw; E W Callahan; R Schmid
Journal:  J Clin Invest       Date:  1970-05       Impact factor: 14.808

9.  Maximal erythrocyte and hemoglobin catabolism.

Authors:  R F Coburn; P B Kane
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

10.  Carbon monoxide production associated with ineffective erythropoiesis.

Authors:  P White; R F Coburn; W J Williams; M I Goldwein; M L Rother; B C Shafer
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.